Stability and blanching potential of corticosteroid ointments.
D000287:Administration, Topical / Q000009:adverse effects; D001623:Betamethasone / Q000031:analogs & derivatives*; D001624:Betamethasone Valerate / Q000009:adverse effects*; D007464:Clioquinol / Q000009:adverse effects*; D004338:Drug Combinations / Q000009:adverse effects; D006801:Humans; D006912:Hydroxyquinolines / Q000009:adverse effects*; D009824:Ointments
D004338:Drug Combinations; D006912:Hydroxyquinolines; D009824:Ointments; C032084:betamethasone 17-valerate, clioquinol drug combination; D007464:Clioquinol; D001623:Betamethasone; D001624:Betamethasone Valerate